ReviewMolecules (Basel, Switzerland)2017
Essential Oils and Their Constituents: An Alternative Source for Novel Antidepressants.
Review in Molecules (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 43 citations in OpenAlex.
- S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial.Psychopharmacology · 2020Trial
- Chemical Composition and Preliminary Screening of Anticholinesterase and Antioxidant Activities of the Essential Oil ofPlants (Basel, Switzerland) · 2026Article
- Evaluation of Chitosan-Pimelate Buccal Film Loaded with Duloxetine-Modified Sage Lipid Carriers Nanoformulation for Effective Antidepressant Activity in a Rat Model.International journal of nanomedicine · 2026Article
- Application ofMolecules (Basel, Switzerland) · 2024Article
- Investigation of the Molecular Mechanisms Underlying the Therapeutic Effect ofCombinatorial chemistry & high throughput screening · 2024Article
- Antidepressant and anxiolytic potential ofFrontiers in pharmacology · 2024Article
- Essential Oils: Chemistry and Pharmacological Activities.Biomolecules · 2023Review
- Polymeric nanoparticles for enhanced delivery and improved bioactivity of essential oils.Heliyon · 2023Review
- Antidepressant Effects of Essential Oils: A Review of the Past Decade (2012-2022) and Molecular Docking Study of Their Major Chemical Components.International journal of molecular sciences · 2023Review
- Preparation, Characterization, and Application of Modified Starch/Chitosan/Sweet Orange Oil Microcapsules.Foods (Basel, Switzerland) · 2022Article
- Inhalation AromatherapyFrontiers in pharmacology · 2022Review
- Essential oils for agitation in dementia [rELOAD]: A pragmatic, cluster-randomized, placebo-controlled, pilot feasibility trial.Integrative medicine research · 2021Article
- Behavioural and biochemical indications of the antidepressant activities of essential oils fromIBRO neuroscience reports · 2021Article
- Investigation of Potential Antioxidant, Thrombolytic and Neuropharmacological Activities ofMolecules (Basel, Switzerland) · 2021Article
- Integrated Network Pharmacology and GC-MS-Based Metabolomics to Investigate the Effect of Xiang-Su Volatile Oil Against Menopausal Depression.Frontiers in pharmacology · 2021Article
- (-)-BioMed research international · 2020Article
- Lead optimization for promising monoamine oxidase inhibitor from eugenol for the treatment of neurological disorder: synthesis and in silico based study.BMC chemistry · 2019Article
- The harmful effects of acute PMScientific reports · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Depression is a disease that has affected a high proportion of the world's population and people of different ages, incapacitating them from good performance at work and in social relationships, and causing emotional disorders to millions of families. Therefore, the search for new therapeutic agents is considered a priority for the discovery of more effective forms of treatment. In this review, studies of essential oils and their constituents in experimental models related to depression are discussed. The mechanisms of action of the oils and the presence of psychoactive constituents in their chemical compositions are discussed. The data in the review show the therapeutic potential of essential oils and their chemical constituents for use in depressive disorders. Advanced studies using humans are needed to confirm the antidepressant properties described in animals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.